Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Rhythm Pharmaceuticals buy Citigroup Inc.

Rhythm Pharmaceuticals
Start price
€77.50
17.03.26 / 50%
Target price
€113.94
17.03.27
Performance (%)
-7.10%
Price
€71.50
10.04.26
Summary
This prediction is currently active. With a performance of -7.10%, the BUY prediction for Rhythm Pharmaceuticals by Citigroup_Inc_ is down slightly. This prediction currently runs until 17.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Rhythm Pharmaceuticals -2.667%
iShares Core DAX® 2,55 %
iShares Nasdaq 100 2,74 %
iShares Nikkei 225® 6,58 %
iShares S&P 500 1,93 %

Comments by Citigroup_Inc_ for this prediction

In the thread Rhythm Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -7.10%
Target price 113.944
Change
Ends at 17.03.27

Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat

Citigroup Inc. 
0
Report Share
17.03.26

Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€93.00
27.11.25
€117.12
27.11.26
-22.58%
10.04.26

Citigroup Inc. 
27.11.25 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€83.00
25.09.25
-
25.09.26
-12.05%
10.04.26

Citigroup Inc. 
25.09.25 50%